Literature DB >> 21618027

A miR-21 inhibitor enhances apoptosis and reduces G(2)-M accumulation induced by ionizing radiation in human glioblastoma U251 cells.

Yi Li1, Shiguang Zhao, Yunbo Zhen, Qiang Li, Lei Teng, Akio Asai, Keiji Kawamoto.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNAs that take part in diverse biological processes by suppressing target gene expression. Elevated expression of miR-21 has been reported in many types of human cancers. Radiotherapy is a standard adjuvant treatment for patients with glioblastoma. However, the resistance of glioblastoma cells to radiation limits the success of this treatment. In this study, we found that miR-21 expression was upregulated in response to ionizing radiation (IR) in U251 cells, which suggested that miR-21 could be involved in the response of U251 cells to radiation. We showed that a miR-21 inhibitor enhanced IR-induced glioblastoma cell growth arrest and increased the level of apoptosis, which was probably caused by abrogation of the G(2)-M arrest induced by IR. Further research demonstrated that the miR-21 inhibitor induced the upregulation of Cdc25A. Taken together, these findings suggest that miR-21 inhibitor can increase IR-induced growth arrest and apoptosis in U251 glioblastoma cells, at least in part by abrogating G(2)-M arrest, and that Cdc25A is a potential target of miR-21.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21618027     DOI: 10.1007/s10014-011-0037-1

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  28 in total

1.  Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma.

Authors:  Young-Eun Seo; Hee-Won Suh; Raman Bahal; Alexander Josowitz; Junwei Zhang; Eric Song; Jiajia Cui; Seth Noorbakhsh; Christopher Jackson; Tom Bu; Alexandra Piotrowski-Daspit; Ranjit Bindra; W Mark Saltzman
Journal:  Biomaterials       Date:  2019-02-14       Impact factor: 12.479

Review 2.  microRNAs in cancer cell response to ionizing radiation.

Authors:  Jennifer R Czochor; Peter M Glazer
Journal:  Antioxid Redox Signal       Date:  2014-02-04       Impact factor: 8.401

3.  Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.

Authors:  Yolande Berthois; Christine Delfino; Philippe Metellus; Frederic Fina; Isabelle Nanni-Metellus; Hayat Al Aswy; Victor Pirisi; L'Houcine Ouafik; Françoise Boudouresque
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

Review 4.  MicroRNA-21 is a novel promising target in cancer radiation therapy.

Authors:  Jia Liu; Hongcheng Zhu; Xi Yang; Yangyang Ge; Chi Zhang; Qin Qin; Jing Lu; Liangliang Zhan; Hongyan Cheng; Xinchen Sun
Journal:  Tumour Biol       Date:  2014-01-21

Review 5.  Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors.

Authors:  Agnieszka Bronisz; Jakub Godlewski; E Antonio Chiocca
Journal:  Cell Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.046

6.  RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.

Authors:  Tae Jin Lee; Ji Young Yoo; Dan Shu; Hui Li; Jianying Zhang; Jun-Ge Yu; Alena Cristina Jaime-Ramirez; Mario Acunzo; Giulia Romano; Ri Cui; Hui-Lung Sun; Zhenghua Luo; Matthew Old; Balveen Kaur; Peixuan Guo; Carlo M Croce
Journal:  Mol Ther       Date:  2017-01-18       Impact factor: 11.454

Review 7.  Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy.

Authors:  Akshay Malhotra; Uttam Sharma; Shyamly Puhan; Naga Chandra Bandari; Anjali Kharb; P P Arifa; Lovlesh Thakur; Hridayesh Prakash; Karen M Vasquez; Aklank Jain
Journal:  Biochimie       Date:  2018-10-13       Impact factor: 4.079

Review 8.  MicroRNAs in the ionizing radiation response and in radiotherapy.

Authors:  Chanatip Metheetrairut; Frank J Slack
Journal:  Curr Opin Genet Dev       Date:  2013-02-28       Impact factor: 5.578

9.  Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens.

Authors:  Aysegül Ilhan-Mutlu; Adelheid Wöhrer; Anna Sophie Berghoff; Georg Widhalm; Christine Marosi; Ludwig Wagner; Matthias Preusser
Journal:  J Neurooncol       Date:  2013-02-19       Impact factor: 4.130

10.  The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis.

Authors:  Liang Xue; Yi Wang; Shuyuan Yue; Jianning Zhang
Journal:  Neurol Sci       Date:  2016-09-15       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.